目的:探讨血清癌胚抗原(carcino-embryonic antigen,CEA)、甲胎蛋白(alpha fetoprotein,AFP)及维生素K缺乏或拮抗剂-II诱导的蛋白质(protein induced by vitamin K absence or antagonist-II,PIVKA-II)对肝炎病毒相关肝细胞癌(hepatocel...
Supported by the National Key Clinical Discipline,Fuzhou “14th Five-Year Plan” Clinical Key Specialty (laboratory medicine);the National Science Foundation of China,No. 82002587
BACKGROUND Serum protein induced by vitamin K absence or antagonist-Ⅱ(PIVKA-Ⅱ) is a promising biomarker for hepatocellular carcinoma(HCC) surveillance.AIM To identify the contributing factors related to the abnormal...
This study was supported by Beijing Tsinghua Changgung Hospital Fund(Grant No.12022C1009).
Background and aims:Protein induced by vitamin K absence or antagonist II(PIVKA-II)is a well-accepted biomarker for diagnosing hepatocellular carcinoma(HCC).Although nonspecific increase of PIVKA-II has been reported,...
BACKGROUND In hepatocellular carcinoma(HCC),detection and treatment prior to growth beyond 2 cm are relevant as a larger tumor size is more frequently associated with microvascular invasion and/or satellites.AIM To ex...